Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Evaluation of the airway microbiome in nontuberculous mycobacteria disease.

Sulaiman I, Wu BG, Li Y, Scott AS, Malecha P, Scaglione B, Wang J, Basavaraj A, Chung S, Bantis K, Carpenito J, Clemente JC, Shen N, Bessich J, Rafeq S, Michaud G, Donington J, Naidoo C, Theron G, Schattner G, Garofano S, Condos R, Kamelhar D, Addrizzo-Harris D, Segal LN.

Eur Respir J. 2018 Oct 25;52(4). pii: 1800810. doi: 10.1183/13993003.00810-2018. Print 2018 Oct.

PMID:
30093571
2.

Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendations.

Kazachkov M, Palma JA, Norcliffe-Kaufmann L, Bar-Aluma BE, Spalink CL, Barnes EP, Amoroso NE, Balou SM, Bess S, Chopra A, Condos R, Efrati O, Fitzgerald K, Fridman D, Goldenberg RM, Goldhaber A, Kaufman DA, Kothare SV, Levine J, Levy J, Lubinsky AS, Maayan C, Moy LC, Rivera PJ, Rodriguez AJ, Sokol G, Sloane MF, Tan T, Kaufmann H.

Respir Med. 2018 Aug;141:37-46. doi: 10.1016/j.rmed.2018.06.017. Epub 2018 Jun 21. Review.

3.

Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ.

Wang J, Lesko M, Badri MH, Kapoor BC, Wu BG, Li Y, Smaldone GC, Bonneau R, Kurtz ZD, Condos R, Segal LN.

ERJ Open Res. 2017 Jul 12;3(3). pii: 00008-2017. doi: 10.1183/23120541.00008-2017. eCollection 2017 Jul.

4.

Pulmonary Fibrosis Treated with Inhaled Interferon-gamma (IFN-γ).

Fusiak T, Smaldone GC, Condos R.

J Aerosol Med Pulm Drug Deliv. 2015 Oct;28(5):406-10. doi: 10.1089/jamp.2015.1221. Epub 2015 Sep 1.

PMID:
26327351
5.

Inhaled Interferon and Diffusion Capacity in Idiopathic Pulmonary Fibrosis (IPF).

Skaria SD, Yang J, Condos R, Smaldone GC.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jun 22;32(1):37-42.

PMID:
26237354
6.

Elevated IP-10 and IL-6 from bronchoalveolar lavage cells are biomarkers of non-cavitary tuberculosis.

Nolan A, Condos R, Huie ML, Dawson R, Dheda K, Bateman E, Rom WN, Weiden MD.

Int J Tuberc Lung Dis. 2013 Jul;17(7):922-7. doi: 10.5588/ijtld.12.0610.

7.

Increased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputum.

Nolan A, Fajardo E, Huie ML, Condos R, Pooran A, Dawson R, Dheda K, Bateman E, Rom WN, Weiden MD.

PLoS One. 2013;8(3):e59461. doi: 10.1371/journal.pone.0059461. Epub 2013 Mar 20.

8.

Delivery and safety of inhaled interferon-γ in idiopathic pulmonary fibrosis.

Diaz KT, Skaria S, Harris K, Solomita M, Lau S, Bauer K, Smaldone GC, Condos R.

J Aerosol Med Pulm Drug Deliv. 2012 Apr;25(2):79-87. doi: 10.1089/jamp.2011.0919. Epub 2012 Feb 23.

PMID:
22360317
9.

Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.

Dawson R, Condos R, Tse D, Huie ML, Ress S, Tseng CH, Brauns C, Weiden M, Hoshino Y, Bateman E, Rom WN.

PLoS One. 2009 Sep 15;4(9):e6984. doi: 10.1371/journal.pone.0006984.

10.

The burden of exposure-related diffuse lung disease.

Goldyn SR, Condos R, Rom WN.

Semin Respir Crit Care Med. 2008 Dec;29(6):591-602. doi: 10.1055/s-0028-1101269. Epub 2009 Feb 16.

11.

Mycobacterium tuberculosis induces CCL18 expression in human macrophages.

Ferrara G, Bleck B, Richeldi L, Reibman J, Fabbri LM, Rom WN, Condos R.

Scand J Immunol. 2008 Dec;68(6):668-74. doi: 10.1111/j.1365-3083.2008.02182.x. Epub 2008 Oct 28.

12.

Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.

Newton TF, Reid MS, De La Garza R, Mahoney JJ, Abad A, Condos R, Palamar J, Halkitis PN, Mojisak J, Anderson A, Li SH, Elkashef A.

Int J Neuropsychopharmacol. 2008 Dec;11(8):1037-45. doi: 10.1017/S1461145708009097. Epub 2008 Jul 29.

13.

Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis.

Condos R, Hadgiangelis N, Leibert E, Jacquette G, Harkin T, Rom WN.

Chest. 2008 Jul;134(1):187-92. doi: 10.1378/chest.07-1988.

PMID:
18628223
14.

Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis.

Condos R, Schluger NW.

BioDrugs. 1999 Mar;11(3):165-73.

PMID:
18031127
15.

Gene expression profiles of bronchoalveolar cells in pulmonary TB.

Raju B, Hoshino Y, Belitskaya-Lévy I, Dawson R, Ress S, Gold JA, Condos R, Pine R, Brown S, Nolan A, Rom WN, Weiden MD.

Tuberculosis (Edinb). 2008 Jan;88(1):39-51. Epub 2007 Oct 24.

16.

Mycobacterium tuberculosis malate synthase- and MPT51-based serodiagnostic assay as an adjunct to rapid identification of pulmonary tuberculosis.

Achkar JM, Dong Y, Holzman RS, Belisle J, Kourbeti IS, Sherpa T, Condos R, Rom WN, Laal S.

Clin Vaccine Immunol. 2006 Nov;13(11):1291-3.

17.

Quality assurance in a large clinical trials consortium: the experience of the Tuberculosis Trials Consortium.

Sandman L, Mosher A, Khan A, Tapy J, Condos R, Ferrell S, Vernon A; Tuberculosis Trials Consortium.

Contemp Clin Trials. 2006 Dec;27(6):554-60. Epub 2006 Jul 28.

PMID:
16876488
18.

Volatile biomarkers of pulmonary tuberculosis in the breath.

Phillips M, Cataneo RN, Condos R, Ring Erickson GA, Greenberg J, La Bombardi V, Munawar MI, Tietje O.

Tuberculosis (Edinb). 2007 Jan;87(1):44-52. Epub 2006 Apr 25.

PMID:
16635588
19.

Regional deposition of aerosolized interferon-gamma in pulmonary tuberculosis.

Condos R, Hull FP, Schluger NW, Rom WN, Smaldone GC.

Chest. 2004 Jun;125(6):2146-55.

PMID:
15189935
20.

Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis.

Raju B, Hoshino Y, Kuwabara K, Belitskaya I, Prabhakar S, Canova A, Gold JA, Condos R, Pine RI, Brown S, Rom WN, Weiden MD.

Infect Immun. 2004 Mar;72(3):1275-83.

21.

Lung deposition and respirable mass during wet nebulization.

Sangwan S, Condos R, Smaldone GC.

J Aerosol Med. 2003 Winter;16(4):379-86.

PMID:
14977428
22.

Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis.

Gold JA, Hoshino Y, Tanaka N, Rom WN, Raju B, Condos R, Weiden MD.

Infect Immun. 2004 Feb;72(2):645-50.

23.
24.
25.

In situ activation of helper T cells in the lung.

Raju B, Tung CF, Cheng D, Yousefzadeh N, Condos R, Rom WN, Tse DB.

Infect Immun. 2001 Aug;69(8):4790-8.

26.

Lung-specific immune response in tuberculosis.

Condos R, Rom WN, Weiden M.

Int J Tuberc Lung Dis. 2000 Feb;4(2 Suppl 1):S11-7. Review. No abstract available.

PMID:
10688143
27.

Local immune responses correlate with presentation and outcome in tuberculosis.

Condos R, Rom WN, Liu YM, Schluger NW.

Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):729-35.

PMID:
9517583
28.

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol.

Condos R, Rom WN, Schluger NW.

Lancet. 1997 May 24;349(9064):1513-5.

PMID:
9167461
29.

Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung.

Nakata K, Rom WN, Honda Y, Condos R, Kanegasaki S, Cao Y, Weiden M.

Am J Respir Crit Care Med. 1997 Mar;155(3):996-1003.

PMID:
9117038
30.

Peripheral-blood-based PCR assay to identify patients with active pulmonary tuberculosis.

Condos R, McClune A, Rom WN, Schluger NW.

Lancet. 1996 Apr 20;347(9008):1082-5.

PMID:
8602060
31.

Human host response to Mycobacterium tuberculosis.

Rom WN, Schluger N, Law K, Condos R, Zhang Y, Weiden M, Harkin T, Tchou-Wong KM.

Schweiz Med Wochenschr. 1995 Nov 11;125(45):2178-85. Review.

PMID:
8525336
32.

Flow limitation as a noninvasive assessment of residual upper-airway resistance during continuous positive airway pressure therapy of obstructive sleep apnea.

Condos R, Norman RG, Krishnasamy I, Peduzzi N, Goldring RM, Rapoport DM.

Am J Respir Crit Care Med. 1994 Aug;150(2):475-80.

PMID:
8049832
33.

Amplification of DNA of Mycobacterium tuberculosis from peripheral blood of patients with pulmonary tuberculosis.

Schluger NW, Condos R, Lewis S, Rom WN.

Lancet. 1994 Jul 23;344(8917):232-3.

PMID:
7913158
34.

Dermahesive: a new concept in surgical dressings.

McDonald IA, McLeish GR, Condos R, Deutschmann P, Kneale BL.

Med J Aust. 1977 Jul 2;2(1):26. No abstract available.

PMID:
895616

Supplemental Content

Loading ...
Support Center